Glaucoma

Even after Robert H. Osher, MD, finished his training and three fellowships, he did not feel comfortable as a cataract surgeon.

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Vance Thompson, MD, discusses his new role as president of the American Society of Cataract and Refractive Surgery.

More than half of all patients treated with glaucoma medications have ocular surface disease, which predominantly manifests as dry eye disease.

BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Pete England, vice president of global marketing at ViaLase, discusses the company’s femtosecond laser platform for the treatment of open-angle glaucoma.

TAMPA, Fla. — In a presentation from Telling It Like It Is, Analisa Arosemena, MD, discussed the path to achieving 24/7 IOP control for patients with glaucoma and the role that canaloplasty may play.

WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Joan Stauffer, director of marketing and communications for Iridex, discusses new laser systems from the company.

ViaLase has secured approximately $40 million in Series C financing to drive the continued development of the company’s femtosecond laser for the treatment of glaucoma, according to a press release.

The first quarter of 2024 has come to a close, but Healio’s ophthalmology meeting news coverage is just getting started.

Both healthy individuals and patients with medically controlled primary open-angle glaucoma experienced a rise in IOP while reading, especially when reading from a smartphone, according to a study published in the Journal of Glaucoma.

The American Optometric Association has released a new, evidence-based clinical practice guideline draft, “Care of the Patient with Primary Open-Angle Glaucoma,” which is available online for peer and public review through April 24.